Sanford Burnham Prebys Medical Discovery Institute (SBP) welcomes the incoming graduate class of 2016:
Ayako Murao (B.A.Sc., Cal State San Marcos) will explore the mechanisms of cancer progression, especially melanoma, in the lab of Ze’ev Ronai, PhD
Katja Birker (BS, University of British Columbia) is joining the lab of Rolf Bodmer, PhD, where she will study heart development in fruit flies.
Joseph Fromm (BS, UCLA) will work under Nicholas Cosford, PhD, designing small molecule inhibitors of cell death to treat cancer.
Pavel Rhyzov (BS, Bonn-Rhein-Sieg University of Applied Sciences) will probe the structure and function of proteins involved in plague infectivity and cell death in the lab of Francesca Marassi, PhD
Since its launch in 2006, SBP’s Graduate School of Biomedical Sciences (GSBS) has awarded PhD degrees to 27 students who have gone on to careers in both academic research and biotechnology. In 2015 the Western Association of Schools and Colleges (WASC) granted accreditation to the GSBS, a distinction that assures the quality of our resources, policies, and practices to achieve educational goals.
“We’re excited to have these great new graduate students,” said Guy Salvesen, PhD, dean of GSBS and professor in the NCI-designated Cancer Center. “Graduate school can be a long haul, but our program allows students to start their research project immediately so that the average time to degree completion is 4.7 years compared to the national average of 6 years.”
“Our Institute provides access to the most sophisticated minds and technologies in biomedical sciences. There has never been a better time for aspiring scientists to explore careers in biomedical sciences, and SBP’s graduate program provides an outstanding environment to embark on this path,” adds Salvesen.
Could you be part of next year’s class? GSBS is accepting applications now.